News

Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
Science Daily1d
Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
News-Medical.Net on MSN3d
Experimental cancer drug shows promise in boosting tuberculosis treatment
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
EurekAlert!3d
Study suggests experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease
TB is caused by Mycobacterium tuberculosis, a type of bacterial species. In early stages, infected lung cells limit spread ... and damage to surrounding tissue. While apoptosis could be compared ...
Public health’s reckoning started with COVID. It was too late.
The field is being taken over by hostile forces. To fight, it must dedicate itself to something larger than saving lives at ...
World of vaccine vibe check
The World Vaccine Congress kicks off its annual conference this week in Washington, bringing together researchers, pharma ...
Le Lézard2d
Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...